<p>(<b>A</b>) RBG was examined weekly during ZBPYR administration. ZBPYR significantly reduced glucose levels from the 3rd week to the 6th week. (<b>B</b>) FSI was accessed at the end of the administration period and after the animals had been starved for 12 h. (<b>C–D</b>) OGTT (2 g/kg body weight) was performed at the end of the administration period and after the animals had been starved for 14 h. Actual glucose levels were measured at the indicated times (<b>C</b>), and then the AUC was analyzed (<b>D</b>). (<b>E–F</b>) ITT (0.75 U/kg body weight) was performed at the end of the administration period and after the animals had been starved for 6 h. Actual glucose levels were measured at the indicated times (<b>E</b>), and then the AUC wa...
<p>KK mice were administrated urantide (30 µg/kg/day) for 14 days prior to calculation of glucose lo...
<p>NOTE: Diabetic mice were treated with BPs (30 and 60 mg/kg/day), glyburide (7.2 mg/kg/day), or ve...
<p>Effect of Metabolex-36 (<b>A</b>) and AZ13581837 (<b>C</b>) on glucose response after an oral glu...
<p>A: body weight of the mice during treatment in each group. B: body weight gain of the mice during...
<p>(A) Blood glucose levels were measured in overnight-fasted female <i>db/db</i> mice (n = 9–10 per...
<p>BDDE was administered orally to db/db mice once a day for 4 weeks. The blood glucose (A), HbA1c l...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>The animals were dosed intraperitoneally once daily with metformin (closed triangles) or twice da...
<p>Newly diagnosed and established diabetic NOD mice were treated with AG490 (i.p, 1 mg/mouse) witho...
<p>The indicated doses of novel compounds (codes and chemical structures shown above the bar graphs)...
<p>Diabetic mice were treated with BPs (30 and 60 mg/kg/day), glyburide (7.2 mg/kg/day), or vehicle ...
<p>(<b>A</b>) ZBPYR did not alter SOCS3 expression, but significantly decreased p-JAK2 (Tyr<sup>1007...
<p><b>a</b>, Plasma glucose levels in male <i>db/db</i> mice that received once daily oral doses of ...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>Permanent hyperglycemia in <i>WT</i> and <i>AMPKα2<sup>-/-</sup></i> mice was induced by a low-do...
<p>KK mice were administrated urantide (30 µg/kg/day) for 14 days prior to calculation of glucose lo...
<p>NOTE: Diabetic mice were treated with BPs (30 and 60 mg/kg/day), glyburide (7.2 mg/kg/day), or ve...
<p>Effect of Metabolex-36 (<b>A</b>) and AZ13581837 (<b>C</b>) on glucose response after an oral glu...
<p>A: body weight of the mice during treatment in each group. B: body weight gain of the mice during...
<p>(A) Blood glucose levels were measured in overnight-fasted female <i>db/db</i> mice (n = 9–10 per...
<p>BDDE was administered orally to db/db mice once a day for 4 weeks. The blood glucose (A), HbA1c l...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>The animals were dosed intraperitoneally once daily with metformin (closed triangles) or twice da...
<p>Newly diagnosed and established diabetic NOD mice were treated with AG490 (i.p, 1 mg/mouse) witho...
<p>The indicated doses of novel compounds (codes and chemical structures shown above the bar graphs)...
<p>Diabetic mice were treated with BPs (30 and 60 mg/kg/day), glyburide (7.2 mg/kg/day), or vehicle ...
<p>(<b>A</b>) ZBPYR did not alter SOCS3 expression, but significantly decreased p-JAK2 (Tyr<sup>1007...
<p><b>a</b>, Plasma glucose levels in male <i>db/db</i> mice that received once daily oral doses of ...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>Permanent hyperglycemia in <i>WT</i> and <i>AMPKα2<sup>-/-</sup></i> mice was induced by a low-do...
<p>KK mice were administrated urantide (30 µg/kg/day) for 14 days prior to calculation of glucose lo...
<p>NOTE: Diabetic mice were treated with BPs (30 and 60 mg/kg/day), glyburide (7.2 mg/kg/day), or ve...
<p>Effect of Metabolex-36 (<b>A</b>) and AZ13581837 (<b>C</b>) on glucose response after an oral glu...